Jeff Jones Score: 27
Analyst at
Oppenheimer
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+3.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
50%
10 W / 10 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
47%
9 W / 10 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
11%
2 W / 17 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 19 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
44%
7 W / 9 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
53%
10 W / 9 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jan 06, 2026 |
Alumis Inc.
ALMS
|
BUY |
$50.00
Est. +208%
|
$16.23 | $30.51 |
Pending
|
$24.15
+48.8%
|
| Nov 14, 2025 |
Oppenheimer Holdings Inc - Ordinary Shares - Class A
OPY
|
SELL |
$57.00
Est. +15%
|
$67.40 | $63.81 (Low) |
Pending
|
$107.05
-58.8%
|
| Nov 04, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$67.00
Est. +12%
|
$59.91 | $103.00 |
Target Met
|
$85.59
+42.9%
|
| Jun 27, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$53.00
Est. +20%
|
$44.12 | $103.00 |
Target Met
|
$85.59
+94.0%
|
| Nov 08, 2024 |
PMV Pharmaceuticals Inc
PMVP
|
BUY |
$6.00
Est. +243%
|
$1.75 | $1.84 |
Miss
|
$1.06
-39.4%
|
| Oct 21, 2024 |
Corbus Pharmaceuticals Holdings Inc
CRBP
|
BUY |
$60.00
Est. +226%
|
$18.41 | $20.77 |
Miss
|
$8.32
-54.8%
|
| Oct 14, 2024 |
Perspective Therapeutics Inc
CATX
|
BUY |
$22.00
Est. +74%
|
$12.66 | $13.19 |
Miss
|
$2.95
-76.7%
|
| Sep 27, 2024 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$56.00
Est. +13%
|
$49.47 | $56.81 |
Precision Hit (±3%)
|
$85.59
+73.0%
|
| Aug 07, 2024 |
Corbus Pharmaceuticals Holdings Inc
CRBP
|
BUY |
$88.00
Est. +82%
|
$48.30 | $61.85 |
Miss
|
$8.32
-82.8%
|
| Jul 22, 2024 |
ArriVent BioPharma Inc.
AVBP
|
BUY |
$35.00
Est. +86%
|
$18.77 | $36.20 |
Target Met
|
$30.54
+62.7%
|
| Jun 18, 2024 |
Perspective Therapeutics Inc
CATX
|
BUY |
$19.00
Est. +59%
|
$11.93 | $16.54 |
Miss
|
$2.95
-75.3%
|
| Jun 06, 2024 |
Ventyx Biosciences Inc
VTYX
|
BUY |
$10.00
Est. +89%
|
$5.28 | $3.39 |
Miss
|
$14.00
+165.2%
|
| Jun 03, 2024 |
Corbus Pharmaceuticals Holdings Inc
CRBP
|
BUY |
$80.00
Est. +87%
|
$42.80 | $61.90 |
Miss
|
$8.32
-80.6%
|
| May 15, 2024 |
Perspective Therapeutics Inc
CATX
|
BUY |
$2.00
Est. +27%
|
$1.57 | $16.54 |
Target Met
|
$2.95
+87.9%
|
| May 07, 2024 |
Pliant Therapeutics Inc
PLRX
|
BUY |
$48.00
Est. +248%
|
$13.79 | $16.07 |
Miss
|
$1.14
-91.7%
|
| May 03, 2024 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$52.00
Est. +43%
|
$36.30 | $53.27 |
Precision Hit (±3%)
|
$85.59
+135.8%
|
| Mar 28, 2024 |
Cellectar Biosciences Inc
CLRB
|
BUY |
$12.00
Est. +230%
|
$3.64 | $124.50 |
Target Met
|
$2.34
-35.7%
|
| Mar 12, 2024 |
Ventyx Biosciences Inc
VTYX
|
BUY |
$12.00
Est. +43%
|
$8.42 | $3.39 |
Miss
|
$14.00
+66.3%
|
| Sep 29, 2023 |
Fusion Pharmaceuticals Inc
FUSN
|
BUY | $13.00 | $0.00 | $21.58 |
Target Met
|
- |
| Aug 18, 2023 |
Corvus Pharmaceuticals Inc
CRVS
|
BUY |
$7.00
Est. +220%
|
$2.19 | $4.10 |
Miss
|
$11.90
+443.4%
|
| Dec 08, 2022 |
Prometheus Biosciences Inc
RXDX
|
BUY |
$125.00
Est. +7%
|
$117.21 | $199.96 |
Target Met
|
$199.92
+70.6%
|
Alumis Inc.
ALMS
Jan 06, 2026
Signal & Target
BUY
$50.00
Start Price
$16.23
Best Price (1Y)
$30.51
Current Price
$24.15
Return
+48.8%
Signal & Target
SELL
$57.00
Start Price
$67.40
Best Price (1Y)
$63.81
Current Price
$107.05
Return
-58.8%
Kymera Therapeutics Inc
KYMR
Nov 04, 2025
Signal & Target
BUY
$67.00
Start Price
$59.91
Best Price (1Y)
$103.00
Current Price
$85.59
Return
+42.9%
Kymera Therapeutics Inc
KYMR
Jun 27, 2025
Signal & Target
BUY
$53.00
Start Price
$44.12
Best Price (1Y)
$103.00
Current Price
$85.59
Return
+94.0%
PMV Pharmaceuticals Inc
PMVP
Nov 08, 2024
Signal & Target
BUY
$6.00
Start Price
$1.75
Best Price (1Y)
$1.84
Current Price
$1.06
Return
-39.4%
Corbus Pharmaceuticals Holdings Inc
CRBP
Oct 21, 2024
Signal & Target
BUY
$60.00
Start Price
$18.41
Best Price (1Y)
$20.77
Current Price
$8.32
Return
-54.8%
Perspective Therapeutics Inc
CATX
Oct 14, 2024
Signal & Target
BUY
$22.00
Start Price
$12.66
Best Price (1Y)
$13.19
Current Price
$2.95
Return
-76.7%
Kymera Therapeutics Inc
KYMR
Sep 27, 2024
Signal & Target
BUY
$56.00
Start Price
$49.47
Best Price (1Y)
$56.81
Current Price
$85.59
Return
+73.0%
Corbus Pharmaceuticals Holdings Inc
CRBP
Aug 07, 2024
Signal & Target
BUY
$88.00
Start Price
$48.30
Best Price (1Y)
$61.85
Current Price
$8.32
Return
-82.8%
ArriVent BioPharma Inc.
AVBP
Jul 22, 2024
Signal & Target
BUY
$35.00
Start Price
$18.77
Best Price (1Y)
$36.20
Current Price
$30.54
Return
+62.7%
Perspective Therapeutics Inc
CATX
Jun 18, 2024
Signal & Target
BUY
$19.00
Start Price
$11.93
Best Price (1Y)
$16.54
Current Price
$2.95
Return
-75.3%
Ventyx Biosciences Inc
VTYX
Jun 06, 2024
Signal & Target
BUY
$10.00
Start Price
$5.28
Best Price (1Y)
$3.39
Current Price
$14.00
Return
+165.2%
Corbus Pharmaceuticals Holdings Inc
CRBP
Jun 03, 2024
Signal & Target
BUY
$80.00
Start Price
$42.80
Best Price (1Y)
$61.90
Current Price
$8.32
Return
-80.6%
Perspective Therapeutics Inc
CATX
May 15, 2024
Signal & Target
BUY
$2.00
Start Price
$1.57
Best Price (1Y)
$16.54
Current Price
$2.95
Return
+87.9%
Pliant Therapeutics Inc
PLRX
May 07, 2024
Signal & Target
BUY
$48.00
Start Price
$13.79
Best Price (1Y)
$16.07
Current Price
$1.14
Return
-91.7%
Kymera Therapeutics Inc
KYMR
May 03, 2024
Signal & Target
BUY
$52.00
Start Price
$36.30
Best Price (1Y)
$53.27
Current Price
$85.59
Return
+135.8%
Cellectar Biosciences Inc
CLRB
Mar 28, 2024
Signal & Target
BUY
$12.00
Start Price
$3.64
Best Price (1Y)
$124.50
Current Price
$2.34
Return
-35.7%
Ventyx Biosciences Inc
VTYX
Mar 12, 2024
Signal & Target
BUY
$12.00
Start Price
$8.42
Best Price (1Y)
$3.39
Current Price
$14.00
Return
+66.3%
Fusion Pharmaceuticals Inc
FUSN
Sep 29, 2023
Signal & Target
BUY
$13.00
Start Price
$0.00
Best Price (1Y)
$21.58
Current Price
-
Return
-
Corvus Pharmaceuticals Inc
CRVS
Aug 18, 2023
Signal & Target
BUY
$7.00
Start Price
$2.19
Best Price (1Y)
$4.10
Current Price
$11.90
Return
+443.4%
Prometheus Biosciences Inc
RXDX
Dec 08, 2022
Signal & Target
BUY
$125.00
Start Price
$117.21
Best Price (1Y)
$199.96
Current Price
$199.92
Return
+70.6%